FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207634468> ?p ?o ?g. }

• W3207634468 endingPage "10" @default.
• W3207634468 startingPage "9" @default.
• W3207634468 abstract "Guillain-Barré syndrome (GBS) has been associated with SARS-CoV-2 infection in adults and children,1Abu-Rumeileh S. Abdelhak A. Foschi M. Tumani H. Otto M. Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.J Neurol. 2021; 268: 1133-1170Crossref PubMed Scopus (207) Google Scholar and it has been noted as an adverse effect with the Janssen COVID-19 vaccine in adults.2Janssen COVID-19 vaccine EUA fact sheet for healthcare providers.https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.htmlDate accessed: August 13, 2021Google Scholar There have been no cases reported of children developing GBS after COVID-19 vaccination, to our knowledge. We describe a child who developed GBS within one month of the administration of the second dose of the Pfizer-BioNTech COVID-19 vaccine. Our patient is a 14-year-old male who received the second dose of the Pfizer-BioNTech COVID-19 vaccine on June 11, 2021. He had previously never been diagnosed with COVID-19. On July 3, he experienced left lower extremity swelling up to the knee after a probable bee sting to the bottom of his left second toe, which resolved within two weeks without treatment. On July 11, he reported subjective facial weakness and subjective tongue swelling, for which he received oral prednisone at an urgent care facility. Owing to increasing facial weakness, he was evaluated in the emergency department on July 14, and he underwent diagnostic testing for common causes of facial palsy. No other weakness was reported on examination at that time. He was admitted on July 19 for progressive facial and limb weakness with areflexia. COVID-19 antigen testing was negative upon admission. On examination, he had significant difficulty ambulating, bilateral facial weakness worse on the left, and 4+/5 strength throughout the left hemibody but preserved strength on the right side. Over the next few days, he became quadriparetic and was unable to ambulate independently. Breathing was never impaired. This child's diagnosis of GBS was confirmed through clinical presentation; cerebrospinal fluid showing 4 white blood cells and 165 mg/dL protein, indicating cytoalbuminocytologic dissociation; and electrodiagnostic studies demonstrating a severe, generalized polyradiculoneuropathy, with demyelinating features indicating the acute inflammatory demyelinating polyradiculoneuropathy variant of GBS. Although this patient did not have any sensory losses, both acute inflammatory demyelinating polyradiculoneuropathy and the acute motor axonal neuropathy variants can cause pure motor symptoms.3Willison H.J. Jacobs B.C. van Doorn P.A. Guillain-Barre syndrome.Lancet. 2016; 388: 717-727Abstract Full Text Full Text PDF PubMed Scopus (794) Google Scholar Additional cerebrospinal fluid and serum testing excluded alternative etiologies, including negative Lyme antibodies, Lyme polymerase chain reaction, and ganglioside antibodies. Our patient was treated with 2 g/kg IVIg over 3 days. Beginning on the third day of his IVIg course, he demonstrated marked improvement in his facial and limb weakness. Before discharge, he was able to ambulate with assistance and went home with outpatient physical therapy seven days after admission. At his follow-up appointment in mid-August, he reported full resolution of his neurologic symptoms, and no neurologic abnormalities were noted on physical examination. We are unaware of other pediatric cases of GBS reported in association with a COVID-19 vaccination. Although our patient experienced a probable bee sting in the time after his vaccination, we find it unlikely that this was a direct cause of our patient's GBS given the scarcity of case reports on this association4Saini A.G. Sankhyan N. Suthar R. Singhi P. Acute axonal polyneuropathy following honey-bee sting: a case report.J Child Neurol. 2014; 29: 674-676Crossref Scopus (4) Google Scholar and the quick resolution of localized symptoms. Following the 1976 National Influenza Immunization Program, which was associated with an increased risk of GBS up to 10 weeks after administration, there has been intense scrutiny of subsequent influenza vaccines. Results from analyses of subsequent vaccines have been uneven but are associated with at least a slight increased risk of GBS after many vaccinations in both children5Wise M.E. Viray M. Sejvar J.J. et al.Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.Am J Epidemiol. 2012; 175: 1110-1119Crossref PubMed Scopus (75) Google Scholar and adults,6Schonberger L.B. Bregman D.J. Sullivan-Bolyai J.Z. et al.Guillain-barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.Am J Epidemiol. 1979; 110: 105-123Crossref PubMed Scopus (659) Google Scholar suggesting an etiological linkage. COVID-19 vaccines could trigger GBS via molecular mimicry or via a nonspecific immune response to the vaccine. The incidence of GBS in children is 0.34 to 1.34 cases per 100,000 person,7Sejvar J.J. Baughman A.L. Wise M. Morgan O.W. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis.Neuroepidemiology. 2011; 36: 123-133Crossref PubMed Scopus (525) Google Scholar so it is also possible that this case occurred coincidentally with the vaccine. The onset of GBS within six weeks of vaccination suggests a possible causative association, but large-scale epidemiologic studies are required to determine if COVID-19 vaccination increases the risk of GBS in this population. “Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent” [Pediatric Neurology, Volume 126, January 2022, Pages 9-10]Pediatric NeurologyVol. 128PreviewThe authors regret that a significant error regarding this article's author order. The current author order is: Emily Malamud, Scott Otallah, James Caress, Daniel Lapid. The corrected order should be: Emily Malamud, James Caress, Daniel Lapid, Scott Otallah. The first author would like to apologize for any incovenience caused. Full-Text PDF" @default.
• W3207634468 created "2021-10-25" @default.
• W3207634468 creator A5044711150 @default.
• W3207634468 creator A5050229912 @default.
• W3207634468 creator A5056240044 @default.
• W3207634468 creator A5063802586 @default.
• W3207634468 date "2022-01-01" @default.
• W3207634468 modified "2023-10-01" @default.
• W3207634468 title "Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent" @default.
• W3207634468 cites W1971947774 @default.
• W3207634468 cites W2053526292 @default.
• W3207634468 cites W2103681607 @default.
• W3207634468 cites W2209977920 @default.
• W3207634468 cites W2335127767 @default.
• W3207634468 doi "https://doi.org/10.1016/j.pediatrneurol.2021.10.003" @default.
• W3207634468 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8498800" @default.
• W3207634468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34717201" @default.
• W3207634468 hasPublicationYear "2022" @default.
• W3207634468 type Work @default.
• W3207634468 sameAs 3207634468 @default.
• W3207634468 citedByCount "15" @default.
• W3207634468 countsByYear W32076344682022 @default.
• W3207634468 countsByYear W32076344682023 @default.
• W3207634468 crossrefType "journal-article" @default.
• W3207634468 hasAuthorship W3207634468A5044711150 @default.
• W3207634468 hasAuthorship W3207634468A5050229912 @default.
• W3207634468 hasAuthorship W3207634468A5056240044 @default.
• W3207634468 hasAuthorship W3207634468A5063802586 @default.
• W3207634468 hasBestOaLocation W32076344681 @default.
• W3207634468 hasConcept C126322002 @default.
• W3207634468 hasConcept C141071460 @default.
• W3207634468 hasConcept C159047783 @default.
• W3207634468 hasConcept C16005928 @default.
• W3207634468 hasConcept C187212893 @default.
• W3207634468 hasConcept C197934379 @default.
• W3207634468 hasConcept C22070199 @default.
• W3207634468 hasConcept C2778691916 @default.
• W3207634468 hasConcept C2778720950 @default.
• W3207634468 hasConcept C2779134260 @default.
• W3207634468 hasConcept C2780247198 @default.
• W3207634468 hasConcept C3008058167 @default.
• W3207634468 hasConcept C524204448 @default.
• W3207634468 hasConcept C71924100 @default.
• W3207634468 hasConceptScore W3207634468C126322002 @default.
• W3207634468 hasConceptScore W3207634468C141071460 @default.
• W3207634468 hasConceptScore W3207634468C159047783 @default.
• W3207634468 hasConceptScore W3207634468C16005928 @default.
• W3207634468 hasConceptScore W3207634468C187212893 @default.
• W3207634468 hasConceptScore W3207634468C197934379 @default.
• W3207634468 hasConceptScore W3207634468C22070199 @default.
• W3207634468 hasConceptScore W3207634468C2778691916 @default.
• W3207634468 hasConceptScore W3207634468C2778720950 @default.
• W3207634468 hasConceptScore W3207634468C2779134260 @default.
• W3207634468 hasConceptScore W3207634468C2780247198 @default.
• W3207634468 hasConceptScore W3207634468C3008058167 @default.
• W3207634468 hasConceptScore W3207634468C524204448 @default.
• W3207634468 hasConceptScore W3207634468C71924100 @default.
• W3207634468 hasLocation W32076344681 @default.
• W3207634468 hasLocation W32076344682 @default.
• W3207634468 hasLocation W32076344683 @default.
• W3207634468 hasLocation W32076344684 @default.
• W3207634468 hasOpenAccess W3207634468 @default.
• W3207634468 hasPrimaryLocation W32076344681 @default.
• W3207634468 hasRelatedWork W1511775759 @default.
• W3207634468 hasRelatedWork W1976533074 @default.
• W3207634468 hasRelatedWork W1980310072 @default.
• W3207634468 hasRelatedWork W2022697484 @default.
• W3207634468 hasRelatedWork W2108640155 @default.
• W3207634468 hasRelatedWork W2290087285 @default.
• W3207634468 hasRelatedWork W2996907545 @default.
• W3207634468 hasRelatedWork W3119280007 @default.
• W3207634468 hasRelatedWork W3124935910 @default.
• W3207634468 hasRelatedWork W4225248521 @default.
• W3207634468 hasVolume "126" @default.
• W3207634468 isParatext "false" @default.
• W3207634468 isRetracted "false" @default.
• W3207634468 magId "3207634468" @default.
• W3207634468 workType "article" @default.